Edward G. D. Tuddenham mainly investigates Molecular biology, Internal medicine, Immunology, Mutation and Genetic enhancement. His Molecular biology research includes elements of Recombinant DNA, Complementary DNA, Peptide sequence, Thrombin and Monoclonal antibody. His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology, Endocrinology and Antigen.
His Immunology research includes themes of Stop codon and Haplotype. Edward G. D. Tuddenham has begun a study into Mutation, looking into Genetics and Gene. His biological study spans a wide range of topics, including Virus, Virology, Vector, Factor IX and Viral vector.
Edward G. D. Tuddenham mostly deals with Molecular biology, Immunology, Internal medicine, Genetics and Factor IX. Edward G. D. Tuddenham combines subjects such as Recombinant DNA, Factor VII, Antigen and Antibody, Monoclonal antibody with his study of Molecular biology. Edward G. D. Tuddenham interconnects Liver disease, Pregnancy and Endothelium in the investigation of issues within Immunology.
In Internal medicine, Edward G. D. Tuddenham works on issues like Gastroenterology, which are connected to Coagulopathy. His Factor IX study integrates concerns from other disciplines, such as Haemophilia B, Asymptomatic, Genetic enhancement and Clinical trial. The various areas that Edward G. D. Tuddenham examines in his Genetic enhancement study include Virus, Viral vector and Vector.
His primary scientific interests are in Internal medicine, Genetic enhancement, Immunology, Factor IX and Von Willebrand factor. The study incorporates disciplines such as Gastroenterology and Oncology in addition to Internal medicine. His studies in Genetic enhancement integrate themes in fields like Molecular biology, Vector, Recombinant DNA and Virus.
His Vector study integrates concerns from other disciplines, such as Transgene and Alipogene tiparvovec. His Immunology study incorporates themes from Biophysics, Pregnancy, Endocrinology and Viral vector. His studies deal with areas such as Haemophilia B, Asymptomatic, Surgery and Clinical trial as well as Factor IX.
His scientific interests lie mostly in Genetic enhancement, Virus, Factor IX, Immunology and Internal medicine. His Genetic enhancement research integrates issues from Vector, Viral vector, Molecular biology and Virology. His research investigates the connection between Molecular biology and topics such as In vivo that intersect with problems in Mutation.
His biological study spans a wide range of topics, including Protein structure, Gene and Mutation database. The concepts of his Immunology study are interwoven with issues in Biological activity and Function. His research on Internal medicine often connects related topics like Gastroenterology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B
Amit C. Nathwani;Edward G.D. Tuddenham;Savita Rangarajan;Cecilia Rosales.
The New England Journal of Medicine (2011)
Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2
Simone Rost;Andreas Fregin;Vytautas Ivaskevicius;Ernst Conzelmann.
The hemophilias--from royal genes to gene therapy.
Pier M. Mannucci;Edward G.D. Tuddenham.
The New England Journal of Medicine (2001)
Structure of human factor VIII.
Gordon A. Vehar;Bruce Keyt;Dan Eaton;Henry Rodriguez.
Long-term safety and efficacy of factor IX gene therapy in hemophilia B
Amit C Nathwani;Ulreke M Reiss;Edward G D Tuddenham;Cecilia Rosales;Cecilia Rosales.
The New England Journal of Medicine (2014)
Expression of active human factor VIII from recombinant DNA clones
William I. Wood;Daniel J. Capon;Christian C. Simonsen;Dan L. Eaton.
Biopsy of human preimplantation embryos and sexing by DNA amplification.
A.H. Handyside;R.J.A. Penketh;R.M.L. Winston;J.K. Pattinson.
The Lancet (1989)
Haemophilia A: mutation type determines risk of inhibitor formation.
Rainer Schwaab;H.-H. Brackmann;C. Meyer;J. Seehafer.
Thrombosis and Haemostasis (1995)
Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver
Amit C. Nathwani;John T. Gray;Catherine Y. C. Ng;Junfang Zhou.
Distribution of factor VIII mRNA and antigen in human liver and other tissues
Karen L. Wion;Deirdre Kelly;John A. Summerfield;Edward G. D. Tuddenham.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: